Castle Biosciences Chief Commercial Officer Juvenal Tobin disposes of USD 221,875.04 in common shares - CSTL News | RalliesCastle Biosciences Chief Commercial Officer Juvenal Tobin disposes of USD 221,875.04 in common shares
C
CSTL• Insider sale disclosed in SEC filing
- Castle Biosciences Chief Commercial Officer Juvenal Tobin W sold 6,600 common shares on Sept. 14-15, SEC filing shows.
- Sales were priced at USD 32.32 to USD 35.14 per share, for about USD 221,200 in total proceeds.
- Direct holding fell to 58,584 common shares following the transactions.
•
